Bristol-Myers beats 3rd-qtr forecasts as top drugs deliver
October 24, 2014 at 07:41 AM EDT
Oct 24 (Reuters) - Bristol-Myers Squibb Co reported better-than-expected third-quarter results, fueled by strong sales of its treatments for blood clots, cancer and arthritis.